Key Takeaways
Major U.S. Investment:Â Eli Lilly announced a $5 billion facility in Virginia as part of a $27 billion plan to expand drug manufacturing across America over the next five years.
Policy Pressure Pays: The move follows President Trump’s call for Big...
Key Takeaways
Massive U.S. Commitment:Â British drugmaker GSK announced a five-year, $30 billion investment in U.S. research, development, and manufacturing, including...
